Fludarabine: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz No edit summary |
||
| Line 2: | Line 2: | ||
In [[medicine]], [[fludarabine]] is a [[medication]] that is a [[antineoplastic agent]]. It is approved by the U.S. Food and Drug Administration for the palliative treatment [[chronic lymphocytic leukemia]] (CLL). | In [[medicine]], [[fludarabine]] is a [[medication]] that is a [[antineoplastic agent]]. It is approved by the U.S. Food and Drug Administration for the palliative treatment [[chronic lymphocytic leukemia]] (CLL). | ||
==References== | ==References== | ||
<references/> | <references/> | ||
==External links== | ==External links== | ||
{{CZMed}} | {{CZMed}} | ||
Revision as of 18:10, 11 April 2009
In medicine, fludarabine is a medication that is a antineoplastic agent. It is approved by the U.S. Food and Drug Administration for the palliative treatment chronic lymphocytic leukemia (CLL).
References
External links
The most up-to-date information about Fludarabine and other drugs can be found at the following sites.
- Fludarabine - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Fludarabine - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Fludarabine - Detailed information from DrugBank.